Genes, ageing and longevity in humans: Problems, advantages and perspectives

References

• Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298–300
   PubMedGoogle Scholar
• Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: An epidemiologic view. Blood Coagul Fibrinolysis 1999, Suppl 1: S9–S12
   PubMedGoogle Scholar
• Chait A, Han CY, Oram JF, Heinecke JW. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: Markers or mediators of cardiovascular disease?. J Lipid Res 2005; 46: 389–403
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis—an update. N Engl J Med 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar
• Jaouad L, Milochevitch C, Khalil A. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radic Res 2003; 37: 77–83
   PubMed Web of Science ®Google Scholar
• La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, Standiford TJ. On the physiological role(s) of the paraoxonases. Chem Biol Interact 1999; 119–120: 379–388
   PubMed Web of Science ®Google Scholar
• Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995; 96: 2882–2891
   PubMed Web of Science ®Google Scholar
• Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394: 284–287
   PubMed Web of Science ®Google Scholar
• Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G, Cheroutre H, Faull KF, Berliner JA, Witztum JL, Lusis AJ. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 2000; 275: 17527–17535
   PubMed Web of Science ®Google Scholar
• Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, Lusis AJ, Shih DM. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 2002; 106: 484–490
   PubMed Web of Science ®Google Scholar
• Bonafe M, Marchegiani F, Cardelli M, Olivieri F, Cavallone L, Giovagnetti S, Pieri C, Marra M, Antonicelli R, Troiano L, Gueresi P, Passeri G, Berardelli M, Paolisso G, Barbieri M, Tesei S, Lisa R, De Benedictis G, Franceschi C. Genetic analysis of paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet 2002; 10: 292–296
   PubMed Web of Science ®Google Scholar
• Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, Franceschi C. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol 2004; 39: 629–635
   PubMed Web of Science ®Google Scholar
• Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Capri M, Salvioli S, Valensin S, De Benedictis G, Di Iorio A, Caruso C, Paolisso G, Monti D. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: The lesson of centenarians. Mech Ageing Dev 2005; 126: 351–361
   PubMed Web of Science ®Google Scholar
• Marchegiani F, Marra M, Spazzafumo L, James RW, Boemi M, Olivieri F, Cardelli M, Cavallone L, Bonfigli AR, Franceschi C. Paraoxonase activity and genotype predispose to successful aging. J Gerontol A Biol Sci Med Sci 2006; 61: 541–546
   PubMed Web of Science ®Google Scholar
• Clendenning JB, Humbert R, Green ED, Wood C, Traver D, Furlong CE. Structural organization of the human PON1 gene. Genomics 1996; 35: 586–589
   PubMed Web of Science ®Google Scholar
• Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993; 3: 73–76
   PubMed Web of Science ®Google Scholar
• Adkins S, Gan KN, Mody M, La Du BN. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 1993; 52: 598–608
   PubMed Web of Science ®Google Scholar
• Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 1997; 99: 62–66
   PubMed Web of Science ®Google Scholar
• Marra M, Marchegiani F, Antonicelli R, Sirolla C, Spazzafumo L, Olivieri F, Franceschi C, Testa R, Paolisso G, James RW, Boemi M, Parati G. The PON1192 RR genotype is associated with a higher prevalence of arterial hypertension. J Hypertens 2006; 24(7)1293–1298
   PubMed Web of Science ®Google Scholar
• Heijmans BT, Westendorp RG, Lagaay AM, Knook DL, Kluft C, Slagboom PE. Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 2000; 149: 91–97
   PubMed Web of Science ®Google Scholar
• Christiansen L, Bathum L, Frederiksen H, Christensen K. Paraoxonase 1 polymorphisms and survival. Eur J Hum Genet 2004; 12: 843–847
   PubMed Web of Science ®Google Scholar
• Tan Q, Christiansen L, Bathum L, Li S, Kruse TA, Christensen K. Genetic association analysis of human longevity in cohort studies of elderly subjects: An example of the PON1 gene in the Danish 1905 birth cohort. Genetics 2006; 172: 1821–1828
   PubMed Web of Science ®Google Scholar
• Mackness M, Mackness B. Paraoxonase 1 and atherosclerosis: Is the gene or the protein more important?. Free Radic Biol Med 2004; 37: 1317–1323
   PubMed Web of Science ®Google Scholar
• Seres I, Paragh G, Deschene E, Fulop T, Jr., Khalil A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 2004; 39: 59–66
   PubMed Web of Science ®Google Scholar
• Khalil A, Wagner JR, Lacombe G, Dangoisse V, Fulop T, Jr. Increased susceptibility of low-density lipoprotein (LDL) to oxidation by gamma-radiolysis with age. FEBS Lett 1996; 392: 45–48
   PubMed Web of Science ®Google Scholar
• Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6: 29–32
   PubMed Web of Science ®Google Scholar
• Carrieri G, Bonafe M, De Luca M, Rose G, Varcasia O, Bruni A, Maletta R, Nacmias B, Sorbi S, Corsonello F, Feraco E, Andreev KF, Yashin AI, Franceschi C, De Benedictis G. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum Genet 2001; 108: 194–198
   PubMed Web of Science ®Google Scholar
• Ordovas JM, Mooser V. Genes, lipids and aging: Is it all accounted for by cardiovascular disease risk? Editorial review. Curr Opin Lipidol 2005; 16: 121–126
   PubMed Web of Science ®Google Scholar
• De Benedictis G, Falcone E, Rose G, Ruffolo R, Spadafora P, Baggio G, Bertolini S, Mari D, Mattace R, Monti D, Morellini M, Sansoni P, Franceschi C. DNA multiallelic systems reveal gene/longevity associations not detected by diallelic systems. The APOB locus. Hum Genet 1997; 99: 312–318
   PubMed Web of Science ®Google Scholar
• De Benedictis G, Carotenuto L, Carrieri G, De Luca M, Falcone E, Rose G, Yashin AI, Bonafe M, Franceschi C. Age-related changes of the 3′APOB-VNTR genotype pool in ageing cohorts. Ann Hum Genet 1998; 62: 115–122
   PubMed Web of Science ®Google Scholar
• Varcasia O, Garasto S, Rizza T, Andersen-Ranberg K, Jeune B, Bathum L, Andreev K, Tan Q, Yashin AI, Bonafe M, Franceschi C, De Benedictis G. Replication studies in longevity: Puzzling findings in Danish centenarians at the 3′APOB-VNTR locus. Ann Hum Genet 2001; 65: 371–376
   PubMed Web of Science ®Google Scholar
• Garasto S, Berardelli M, DeRango F, Mari V, Feraco E, De Benedictis G. A study of the average effect of the 3′APOB-VNTR polymorphism on lipidemic parameters could explain why the short alleles ( < 35 repeats) are rare in centenarians. BMC Med Genet 2004; 5: 3
   PubMedGoogle Scholar
• Garasto S, Rose G, Derango F, Berardelli M, Corsonello A, Feraco E, Mari V, Maletta R, Bruni A, Franceschi C, Carotenuto L, De Benedictis G. The study of APOA1, APOC3 and APOA4 variability in healthy ageing people reveals another paradox in the oldest old subjects. Ann Hum Genet 2003; 67: 54–62
   PubMed Web of Science ®Google Scholar
• Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, Cheng S, Shuldiner AR. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003; 290: 2030–2040
   PubMed Web of Science ®Google Scholar
• Cellini E, Nacmias B, Olivieri F, Ortenzi L, Tedde A, Bagnoli S, Petruzzi C, Franceschi C, Sorbi S. Cholesterol ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. Mech Ageing Dev 2005; 126: 826–828
   PubMed Web of Science ®Google Scholar
• Blaschuk O, Burdzy K, Fritz I. Purification and characterization of a cell-aggregating factor (Clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 1983; 258: 7714–7720
   PubMed Web of Science ®Google Scholar
• Jenne DE, Tschopp J. Molecular structure and functional characterization of a human complement cytolysis found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci 1989; 86: 7123–7127
   PubMed Web of Science ®Google Scholar
• Kirszbaum L, Sharpe JA, Murphy B, d'Apice AJF, Classon B, Hudson P, Walker ID. Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: A link between the complement and reproductive systems. EMBO J 1989; 8: 711–718
   PubMed Web of Science ®Google Scholar
• de Silva HV, Harmony JAK, Stuart WD, Gil CM, Robbins J. Apolipoprotein J: Structure and tissue distribution. Biochemistry 1990; 29: 5380–5389
   PubMed Web of Science ®Google Scholar
• Tycko B, Feng L, Nguyen L, Francis A, Hays A, Chung WY, Tang MX, Stern Y, Sahota A, Hendrie H, Mayeux R. Polymorphisms in the human apolipoprotein-J/clusterin gene: Ethnic variation and distribution in Alzheimer's disease. Hum Genet 1996; 98: 430–436
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Petropoulou C, Franceschi C, Gonos ES. Reduced expression levels of the senescence biomarker Clusterin/Apolipoprotein J in lymphocytes from healthy centenarians. Ann N Y Acad Sci 2006; 1067: 294–300
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Gonos ES. Clusterin/Apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 2002; 34: 1430–1448
   PubMed Web of Science ®Google Scholar
• Gonos ES, Burns JS, Mazars GR, Kobrna A, Riley TEW, Barnet SC, Zafarana G, Ludwig R, Ikram Z, Powell AJ, Jat PS. Rat embryo fibroblasts immortalised with SV40 large T antigen undergo senescence upon its inactivation. Mol Cell Biol 1996; 16: 5127–5138
   PubMed Web of Science ®Google Scholar
• Powell AJ, Darmon AJ, Gonos ES, Lam EWF, Peden KWC, Jat PS. Different functions are required for initiation and maintenance of immortalisation of rat embryo fibroblasts by SV40 large T antigen. Oncogene 1999; 18: 7343–7350
   PubMed Web of Science ®Google Scholar
• Gonos ES, Derventzi A, Kveiborg M, Agiostratidou G, Kassem M, Clark BFC, Jat PS, Rattan SIS. Cloning and identification of genes that associate with mammalian senescence. Exp Cell Res 1998; 240: 66–74
   PubMed Web of Science ®Google Scholar
• Dumont P, Burton M, Chen QM, Gonos ES, Frippiat C, Mazarati JB, Eliaers F, Remacle J, Toussaint O. Induction of replicative senescence biomarkers by sublethal successive oxidative stresses in normal human fibroblasts. Free Radic Biol Med 2000; 28: 361–373
   PubMed Web of Science ®Google Scholar
• Petropoulou C, Trougakos IP, Kolettas E, Toussaint O, Gonos ES. Clusterin/apolipoprotein J is a novel biomarker of cellular senescence, that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett 2001; 509: 287–297
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Poulakou M, Stathatos M, Chalikia A, Melidonis A, Gonos ES. Serum levels of the senescence biomarker Clusterin/Apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp Gerontol 2002; 37: 1175–1187
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos ES. Differential effects of Clusterin/Apolipoprotein J on cellular growth and survival. Free Radic Biol Med 2005; 38: 436–449
   PubMed Web of Science ®Google Scholar
• Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES. Silencing expression of the Clusterin/Apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability and cell sensitization to genotoxic and oxidative stress. Cancer Res 2004; 64: 1834–1842
   PubMed Web of Science ®Google Scholar
• Puca AA, Daly MJ, Brewster SJ, Matise TC, Barrett J, Shea-Drinkwater M, Kang S, Joyce E, Nicoli J, Benson E, Kunkel LM, Perls T. A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci USA 2001; 98: 10505–10508
   PubMed Web of Science ®Google Scholar
• Geesaman BJ, Benson E, Brewster SJ, Kunkel LM, Blanche H, Thomas G, Perls TT, Daly MJ, Puca AA. Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan. Proc Natl Acad Sci USA 2003; 100: 14115–141120
   PubMed Web of Science ®Google Scholar
• Beekman M, Blauw GJ, Houwing-Duistermaat JJ, Brandt BW, Westendorp RG, Slagboom PE. Chromosome 4q25, microsomal transfer protein gene, and human longevity: Novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci 2006; 61: 355–362
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787–790
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994; 14: 1521–1528
   PubMed Web of Science ®Google Scholar
• Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010–9014
   PubMed Web of Science ®Google Scholar
• Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 1988; 240: 1546–1548
   PubMed Web of Science ®Google Scholar
• Kirstein M, Aston C, Hintz R, Vlassara H. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 1992; 90: 439–446
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Paolisso G, Ammendola S, Del Buono A, Gambardella A, Riondino M, Tagliamonte MR, Rizzo MR, Carella C, Varricchio M. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 1997; 82: 2204–2209
   PubMed Web of Science ®Google Scholar
• Bonafe M, Barbieri M, Marchegiani F, Olivieri F, Ragno E, Giampieri C, Mugianesi E, Centurelli M, Franceschi C, Paolisso G. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: Cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab 2003; 88: 3299–3304
   PubMed Web of Science ®Google Scholar
• Paolisso G, Gambardella A, Ammendola S, D'Amore A, Balbi V, Varricchio M, D'Onofrio F. Glucose tolerance and insulin action in healthy centenarians. Am J Physiol 1996; 270: E890–E896
   PubMedGoogle Scholar
• Paolisso G, Barbieri M, Rizzo MR, Carella C, Rotondi M, Bonafe M, Franceschi C, Rose G, De Benedictis G. Low insulin resistance and preserved β-cell function contribute to human longevity but are not associated with TH-INS genes. Exp Gerontol 2001; 37: 149–156
   PubMed Web of Science ®Google Scholar
• Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S, Cordera R. Insulin-like growth factor-1 and angiographically documented coronary artery disease. Am J Cardiol 1996; 77: 200–202
   PubMed Web of Science ®Google Scholar
• van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25–31
   PubMed Web of Science ®Google Scholar
• Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor-1 is associated with increased risk of ischemic heart disease: A population-based case-control study. Circulation 2002; 106: 939–944
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 2004; 89: 114–120
   PubMed Web of Science ®Google Scholar
• Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, Paolisso G. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003; 284: E481–E487
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244–254
   PubMed Web of Science ®Google Scholar
• Vanfleteren JR, Braeckman BP. Mechanisms of life span determination in Caenorhabditis elegans. Neurobiol Aging 1999; 20: 487–502
   PubMed Web of Science ®Google Scholar
• Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ, Partridge L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 2001; 292: 104–106
   PubMed Web of Science ®Google Scholar
• Gems D, Partridge L. Insulin/IGF signalling and ageing: Seeing the bigger picture. Curr Opin Genet Dev 2001; 11: 287–292
   PubMed Web of Science ®Google Scholar
• Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R, Kopchick JJ. Insulin-like growth factor 1 (IGF-1) and aging: Controversies and new insights. Biogerontology 2003; 4: 1–8
   PubMed Web of Science ®Google Scholar
• Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003; 299: 1346–1351
   PubMed Web of Science ®Google Scholar
• Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003; 421: 182–187
   PubMed Web of Science ®Google Scholar
• Kenyon C. A conserved regulatory system for aging. Cell 2001; 105: 165–168
   PubMed Web of Science ®Google Scholar
• Hsieh CC, DeFord JH, Flurkey K, Harrison DE, Papaconstantinou J. Effects of the Pit1 mutation on the insulin signaling pathway: Implications on the longevity of the long-lived Snell dwarf mouse. Mech Ageing Dev 2002; 123: 1245–1255
   PubMed Web of Science ®Google Scholar
• Dozmorov I, Bartke A, Miller RA. Array-based expression analysis of mouse liver genes: Effect of age and of the longevity mutant Prop1df. J Gerontol A Biol Sci Med Sci 2001; 56: B72–B80
   PubMed Web of Science ®Google Scholar
• Steger RW, Bartke A, Cecim M. Premature ageing in transgenic mice expressing different growth hormone genes. J Reprod Fertil Suppl 1993; 46: 61–75
   PubMedGoogle Scholar
• Sonntag WE, Lenham JE, Ingram RL. Effects of aging and dietary restriction on tissue protein synthesis: Relationship to plasma insulin-like growth factor-1. J Gerontol 1992; 47: B159–B163
   PubMedGoogle Scholar
• Sonntag WE, Lynch CD, Cefalu WT, Ingram RL, Bennett SA, Thornton PL, Khan AS. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: Inferences from moderate caloric-restricted animals. J Gerontol A Biol Sci Med Sci 1999; 54: B521–B538
   PubMed Web of Science ®Google Scholar
• Kojima T, Kamei H, Aizu T, Arai Y, Takayama M, Nakazawa S, Ebihara Y, Inagaki H, Masui Y, Gondo Y, Sakaki Y, Hirose N. Association analysis between longevity in the Japanese population and polymorphic variants of genes involved in insulin and insulin-like growth factor 1 signaling pathways. Exp Gerontol 2004; 39: 1595–1598
   PubMed Web of Science ®Google Scholar
• van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, Brandt BW, Zwaan BJ, Slagboom PE, Westendorp RG. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005; 4: 79–85
   PubMed Web of Science ®Google Scholar
• Cardelli M, Marchegiani F, Cavallone L, Olivieri F, Giovanetti S, Mugianesi E, Moresi R, Lisa R, Franceschi C. A Polymorphism of the YTHDF2 gene (1p35) located in an Alu-rich genomic domain is associated with human longevity. J Gerontol A Biol Sci Med Sci 2006, in press
   Web of Science ®Google Scholar
• GenBank [Internet]. Bethesda (MD), National Center for Biotechnology Information (US), National Library of Medicine, National Institutes of Health. Available from: http://www.ncbi.nlm.nih.gov/Genbank.
   Google Scholar
• Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 2006; 116: 808–816
   PubMed Web of Science ®Google Scholar
• Haddad JJ. Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: Role for hypoxia-inducible factor-1α. Crit Care 2003; 7: 47–54
   PubMed Web of Science ®Google Scholar
• Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, Sonenshein GE. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: Implications in liver tumor formation. Oncogene 2003; 22: 412–425
   PubMed Web of Science ®Google Scholar
• Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003; 14: S241–S245
   PubMed Web of Science ®Google Scholar
• Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps B, Vina J, Sastre J. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: Therapeutical implications. Curr Drug Targets Inflamm Allergy 2002; 1: 393–403
   PubMedGoogle Scholar
• Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 2003; 278: 19603–19610
   PubMed Web of Science ®Google Scholar
• Tieri P, Valensin S, Latora V, Castellani GC, Marchiori M, Remondini D, Franceschi C. Quantifying the relevance of different mediators in the human immune cell network. Bioinformatics 2005; 21: 1639–1643
   PubMed Web of Science ®Google Scholar
• Cavallone L, Bonafe M, Olivieri F, Cardelli M, Marchegiani F, Giovagnetti S, Di Stasio G, Giampieri C, Mugianesi E, Stecconi R, Sciacca F, Grimaldi LM, De Benedictis G, Lio D, Caruso C, Franceschi C. The role of IL-1 gene cluster in longevity: A study in Italian population. Mech Ageing Dev 2003; 124: 533–538
   PubMed Web of Science ®Google Scholar
• Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceschi C. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001; 31: 2357–2361
   PubMed Web of Science ®Google Scholar
• Wright N, de Lera TL, Garcia-Moruja C, Lillo R, Garcia-Sanchez F, Caruz A, Teixido J. Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: Functional consequences in cell migration and adhesion. Blood 2003; 102: 1978–1984
   PubMed Web of Science ®Google Scholar
• My-Chan Dang P, Elbim C, Marie JC, Chiandotto M, Gougerot-Pocidalo MA, El-Benna J. Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB J 2006, May 23
   Web of Science ®Google Scholar
• Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J 2003; 17: 1183–1185
   PubMed Web of Science ®Google Scholar
• Paolisso G, Tagliamonte MR, Rizzo MR, Manzella D, Gambardella A, Varricchio M. Oxidative stress and advancing age: Results in healthy centenarians. J Am Geriatr Soc 1998; 46: 833–838
   PubMed Web of Science ®Google Scholar
• Barbieri M, Rizzo MR, Manzella D, Grella R, Ragno E, Carbonella M, Abbatecola AM, Paolisso G. Glucose regulation and oxidative stress in healthy centenarians. Exp Gerontol 2003; 38: 137–143
   PubMed Web of Science ®Google Scholar
• Maccio A, Madeddu C, Massa D, Mudu MC, Lusso MR, Gramignano G, Serpe R, Melis GB, Mantovani G. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: Role of inflammation in cancer-related anemia. Blood 2005; 106: 362–367
   PubMed Web of Science ®Google Scholar
• Summers WK. Alzheimer's disease, oxidative injury, and cytokines. J Alzheimers Dis 2004; 6: 651–657
   PubMed Web of Science ®Google Scholar
• Walston J, Xue Q, Semba RD, Ferrucci L, Cappola AR, Ricks M, Guralnik J, Fried LP. Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol 2006; 163: 18–26
   PubMed Web of Science ®Google Scholar
• Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999; 47: 639–646
   PubMed Web of Science ®Google Scholar
• Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Jr., Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: 506–512
   PubMed Web of Science ®Google Scholar
• Hurme M, Lehtimaki T, Jylha M, Karhunen PJ, Hervonen A. Interleukin-6-174G/C polymorphism and longevity: A follow-up study. Mech Ageing Dev 2005; 126: 417–418
   PubMed Web of Science ®Google Scholar
• Christiansen L, Bathum L, Andersen-Ranberg K, Jeune B, Christensen K. Modest implication of interleukin-6 promoter polymorphisms in longevity. Mech Ageing Dev 2004; 125: 391–395
   PubMed Web of Science ®Google Scholar
• Pes GM, Lio D, Carru C, Deiana L, Baggio G, Franceschi C, Ferrucci L, Oliveri F, Scola L, Crivello A, Candore G, Colonna-Romano G, Caruso C. Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin Exp Res 2004; 16: 244–248
   PubMed Web of Science ®Google Scholar
• Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Semeraro C, Capurso A, Panza F. Interleukin 6-174 G/C promoter gene polymorphism in centenarians: No evidence of association with human longevity or interaction with apolipoprotein E alleles. Exp Gerontol 2004; 39: 1109–1114
   PubMed Web of Science ®Google Scholar
• Carrieri G, Marzi E, Olivieri F, Marchegiani F, Cavallone L, Cardelli M, Giovagnetti S, Stecconi R, Molendini C, Trapassi C, De Benedictis G, Kletsas D, Franceschi C. The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: A study in Italian centenarians. Aging Cell 2004; 3: 443–448
   PubMed Web of Science ®Google Scholar
• Okayama N, Hamanaka Y, Suehiro Y, Hasui Y, Nakamura J, Hinoda Y. Association of interleukin-10 promoter single nucleotide polymorphisms -819 T/C and -592 A/C with aging. J Gerontol A Biol Sci Med Sci 2005; 60: 1525–1529
   PubMed Web of Science ®Google Scholar
• Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Franceschi C, Caruso C. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002; 3: 30–33
   PubMed Web of Science ®Google Scholar
• Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C. Genetics, and longevity: Further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 2003; 40: 296–299
   PubMed Web of Science ®Google Scholar
• Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, Hoffmann E, Caruso M, Licastro F, Caldarera CM, Branzi A, Franceschi C, Caruso C. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: Genetic background of male centenarians is protective against coronary heart disease. J Med Genet 2004; 41: 790–794
   PubMed Web of Science ®Google Scholar
• Scola L, Crivello A, Marino V, Gioia V, Serauto A, Candore G, Colonna-Romano G, Caruso C, Lio D. IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: Implication for ageing and life span expectancy. Mech Ageing Dev 2003; 124: 569–572
   PubMed Web of Science ®Google Scholar
• Candore G, Lio D, Colonna Romano G, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: Effect of multiple gene interactions. Autoimmun Rev 2002; 1: 29–35
   PubMedGoogle Scholar
• de Maat MP, Bladbjerg EM, Hjelmborg JB, Bathum L, Jespersen J, Christensen K. Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol 2004; 24: 2168–2173
   PubMed Web of Science ®Google Scholar
• Giacconi R, Cipriano C, Albanese F, Boccoli G, Saba V, Olivieri F, Franceschi C, Mocchegiani E. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol 2004; 39: 621–628
   PubMed Web of Science ®Google Scholar
• Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafe M, Marchegiani F, Cardelli M, Galeazzi R, Giovagnetti S, Perna GP, Franceschi C. Tumor necrosis factor-alpha gene − 308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis 2005; 16: 489–493
   PubMed Web of Science ®Google Scholar
• Antonicelli R, Olivieri F, Bonafe M, Cavallone L, Spazzafumo L, Marchegiani F, Cardelli M, Recanatini A, Testarmata P, Boemi M, Parati G, Franceschi C. The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 2005; 103: 266–271
   PubMed Web of Science ®Google Scholar
• Olivieri F, Antonicelli R, Cardelli M, Marchegiani F, Cavallone L, Mocchegiani E, Franceschi C. Genetic polymorphisms of inflammatory cytokines and myocardial infarction in the elderly. Mech Ageing Dev 2006; 127: 552–559
   PubMed Web of Science ®Google Scholar
• Testa R, Olivieri F, Bonfigli AR, Sirolla C, Boemi M, Marchegiani F, Marra M, Cenerelli S, Antonicelli R, Dolci A, Paolisso G, Franceschi C. Interleukin-6-174 G>C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients. Diabetes Res Clin Pract 2006; 71: 299–305
   PubMed Web of Science ®Google Scholar
• Belluco C, Olivieri F, Bonafe M, Giovagnetti S, Mammano E, Scalerta R, Ambrosi A, Franceschi C, Nitti D, Lise M. -174G> polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res 2003; 9: 2173–2176
   PubMed Web of Science ®Google Scholar
• Licastro F, Grimaldi LM, Bonafe M, Martina C, Olivieri F, Cavallone L, Giovanietti S, Masliah E, Franceschi C. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol Aging 2003; 24: 921–926
   PubMed Web of Science ®Google Scholar
• Franceschi C, Valensin S, Lescai F, Olivieri F, Licastro F, Grimaldi LM, Monti D, De Benedictis G, Bonafe M. Neuroinflammation and the genetics of Alzheimer's disease: The search for a pro-inflammatory phenotype. Aging (Milano) 2001; 13: 163–170
   PubMedGoogle Scholar
• Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, Binetti G, Bonvicini C, Squitti R, Palermo MT, Davis DG, Antuono P, Wekstein DR, Dobrina A, Gennarelli M, Fazio VM. Genotypes and haplotypes in the IL-1 gene cluster: Analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 2005; 26: 455–464
   PubMed Web of Science ®Google Scholar
• Barbieri M, Rizzo MR, Papa M, Acampora R, De Angelis L, Olivieri F, Marchegiani F, Franceschi C, Paolisso G. Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Exp Gerontol 2005; 40: 599–604
   PubMed Web of Science ®Google Scholar
• Salvioli S, Capri M, Valensin S, Tieri P, Monti D, Ottaviani E, Franceschi C. Inflamm-aging, cytokines and aging: State of the art, new hypotheses on the role of mitochondria and new perspectives from system biology. Curr Pharm Des 2006, in press
   PubMed Web of Science ®Google Scholar
• Short R, Williams DD, Bowden DM. Circulating antioxidants as determinants of the rate of biological aging in pigtailed macaques (Macaca nemestrina). J Gerontol A Biol Sci Med Sci 1997; 52: B26–B38
   PubMed Web of Science ®Google Scholar
• Mezzetti A, Lapenna D, Romano F, Costantini F, Pierdomenico SD, De Cesare D, Cuccurullo F, Riario-Sforza G, Zuliani G, Fellin R. Systemic oxidative stress and its relationship with age and illness. Associazione Medica “Sabin”. J Am Geriatr Soc 1996; 44: 823–827
   PubMed Web of Science ®Google Scholar
• Landis GN, Tower J. Superoxide dismutase evolution and life span regulation. Mech Ageing Dev 2005; 126: 365–379
   PubMed Web of Science ®Google Scholar
• Weisiger RA, Fridovich I. Mitochondrial superoxide simutase. Site of synthesis and intramitochondrial localization. J Biol Chem 1973; 248: 4793–4796
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049–6055
   PubMed Web of Science ®Google Scholar
• Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982; 79: 7634–7638
   PubMed Web of Science ®Google Scholar
• Spencer CC, Howell CE, Wright AR, Promislow DE. Testing an ‘aging gene’ in long-lived drosophila strains: Increased longevity depends on sex and genetic background. Aging Cell 2003; 2: 123–130
   PubMed Web of Science ®Google Scholar
• Sun J, Molitor J, Tower J. Effects of simultaneous over-expression of Cu/ZnSOD and MnSOD on Drosophila melanogaster life span. Mech Ageing Dev 2004; 125: 341–349
   PubMed Web of Science ®Google Scholar
• Duttaroy A, Parkes T, Emtage P, Kirby K, Boulianne GL, Wang X, Hilliker AJ, Phillips JP. The manganese superoxide dismutase gene of Drosophila: Structure, expression, and evidence for regulation by MAP kinase. DNA Cell Biol 1997; 16: 391–399
   PubMed Web of Science ®Google Scholar
• Phillips JP, Campbell SD, Michaud D, Charbonneau M, Hilliker AJ. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc Natl Acad Sci USA 1989; 86: 2761–2765
   PubMed Web of Science ®Google Scholar
• Hinerfeld D, Traini MD, Weinberger RP, Cochran B, Doctrow SR, Harry J, Melov S. Endogenous mitochondrial oxidative stress: Neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 2004; 88: 657–667
   PubMed Web of Science ®Google Scholar
• Andersen HR, Jeune B, Nybo H, Nielsen JB, Andersen-Ranberg K, Grandjean P. Low activity of superoxide dismutase and high activity of glutathione reductase in erythrocytes from centenarians. Age Ageing 1998; 27: 643–648
   PubMed Web of Science ®Google Scholar
• Mecocci P, Polidori MC, Troiano L, Cherubini A, Cecchetti R, Pini G, Straatman M, Monti D, Stahl W, Sies H, Franceschi C, Senin U. Free Radic Biol Med 2000; 28: 1243–1248
   PubMed Web of Science ®Google Scholar
• Mutus B, Rabini RA, Franceschi C, Paolisso G, Rizzo MR, Ragno E, Rappelli A, Braconi M, Mazzanti L. Cellular resistance to homocysteine: A key for longevity. Atherosclerosis 2000; 152: 527–528
   PubMed Web of Science ®Google Scholar
• Rabini RA, Moretti N, Staffolani R, Salvolini E, Nanetti L, Franceschi C, Mazzanti L. Reduced susceptibility to peroxidation of erythrocyte plasma membranes from centenarians. Exp Gerontol 2002; 37: 657–663
   PubMed Web of Science ®Google Scholar
• Rabini RA, Vignini A, Martarelli D, Nanetti L, Salvolini E, Rizzo MR, Ragno E, Paolisso G, Franceschi C, Mazzanti L. Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians. Exp Gerontol 2003; 38: 367–371
   PubMed Web of Science ®Google Scholar
• Mazzanti L, Rabini RA, Petruzzi E, Staffolani R, Salvolini E, Vignini A, Braconi M, Franceschi C. Erythrocyte plasma membranes obtained from centenarians show different functional properties. J Am Geriatr Soc 2000; 48: 350–351
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51–88
   PubMed Web of Science ®Google Scholar
• Taioli E, Mari D, Franceschi C, Bonafe M, Monti D, Bertolini S, Marinelli D, Garte S. Polymorphisms of drug-metabolizing enzymes in healthy nonagenarians and centenarians: Difference at GSTT1 locus. Biochem Biophys Res Commun 2001; 280: 1389–1392
   PubMed Web of Science ®Google Scholar
• Geisler SA, Olshan AF, Cai J, Weissler M, Smith J, Bell D. Glutathione S-transferase polymorphisms and survival from head and neck cancer. Head Neck 2005; 27: 232–242
   PubMed Web of Science ®Google Scholar
• Christiansen L, Brasch-Andersen C, Bathum L, Kruse TA, Christensen K. A longitudinal study of the effect of GSTT1 and GSTM1 gene copy number on survival. Mech Ageing Dev 2006; 127: 597–599
   PubMed Web of Science ®Google Scholar
• Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 2001; 23: 795–806
   PubMed Web of Science ®Google Scholar
• Burkle A, Beneke S, Muiras ML. Poly(ADP-ribosyl)ation and aging. Exp Gerontol 2004; 39: 1599–1601
   PubMed Web of Science ®Google Scholar
• Lindahl T, Satoh MS, Poirier GG, Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 1995; 20: 405–411
   PubMed Web of Science ®Google Scholar
• D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999; 342: 249–268
   PubMed Web of Science ®Google Scholar
• de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997; 94: 7303–7307
   PubMed Web of Science ®Google Scholar
• Grube K, Burkle A. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc Natl Acad Sci USA 1992; 89: 11759–11763
   PubMed Web of Science ®Google Scholar
• Beneke S, Alvarez-Gonzalez R, Burkle A. Comparative characterisation of poly(ADP-ribose) polymerase-1 from two mammalian species with different life span. Exp Gerontol 2000; 35: 989–1002
   PubMed Web of Science ®Google Scholar
• Muiras ML, Muller M, Schachter F, Burkle A. Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians. J Mol Med 1998; 76: 346–354
   PubMed Web of Science ®Google Scholar
• Burkle A. PARP-1: A regulator of genomic stability linked with mammalian longevity. Chembiochem 2001; 2: 725–728
   PubMed Web of Science ®Google Scholar
• Skaper SD. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: A strategy for neuroprotection. Ann N Y Acad Sci 2003; 993: 217–228
   PubMed Web of Science ®Google Scholar
• Mabley JG, Soriano FG. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction. Curr Vasc Pharmacol 2005; 3: 247–252
   PubMedGoogle Scholar
• Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N, Franceschi C, Gaetti R, Cavalieri E, Suzuki H. Metallothioneins/PARP1/IL-6 interplay on natural killer cell activity in elderly: Parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev 2003; 124: 459–468
   PubMed Web of Science ®Google Scholar
• De Benedictis G, Carotenuto L, Carrieri G, De Luca M, Falcone E, Rose G, Cavalcanti S, Corsonello F, Feraco E, Baggio G, Bertolini S, Mari D, Mattace R, Yashin AI, Bonafe M, Franceschi C. Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2). Eur J Hum Genet 1998; 6: 534–541
   PubMed Web of Science ®Google Scholar
• Cottet F, Blanche H, Verasdonck P, Le Gall I, Schachter F, Burkle A, Muiras ML. New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: Lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity. J Mol Med 2000; 78: 431–440
   PubMed Web of Science ®Google Scholar
• Burkle A, Diefenbach J, Brabeck C, Beneke S. Ageing ARP. Pharmacol Res 2005; 52: 93–99
   PubMed Web of Science ®Google Scholar
• Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415: 45–53
   PubMed Web of Science ®Google Scholar
• Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Jr., Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215–221
   PubMed Web of Science ®Google Scholar
• Malkin D, Li FP, Strong LC, Fraumeni JF, Jr., Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233–1238
   PubMed Web of Science ®Google Scholar
• Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987; 7: 961–963
   PubMed Web of Science ®Google Scholar
• Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092–1100
   PubMed Web of Science ®Google Scholar
• Bonafe M, Salvioli S, Barbi C, Mishto M, Trapassi C, Gemelli C, Storci G, Olivieri F, Monti D, Franceschi C. p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes. Biochem Biophys Res Commun 2002; 299: 539–541
   PubMed Web of Science ®Google Scholar
• Dumont P, Leu JI, Della Pietra AC, 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357–365
   PubMed Web of Science ®Google Scholar
• Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 2004; 23: 3328–3337
   PubMed Web of Science ®Google Scholar
• Bonafe M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, Invidia L, Vannini I, Rossi M, Marzi E, Mishto M, Capri M, Olivieri F, Antonicelli R, Memo M, Uberti D, Nacmias B, Sorbi S, Monti D, Franceschi C. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ 2004; 11: 962–973
   PubMed Web of Science ®Google Scholar
• Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004; 108: 196–199
   PubMed Web of Science ®Google Scholar
• Salvioli S, Bonafe M, Barbi C, Storci G, Trapassi C, Tocco F, Gravina S, Rossi M, Tiberi L, Mondello C, Monti D, Franceschi C. p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1. Cell Cycle 2005; 4: 1264–1271
   PubMed Web of Science ®Google Scholar
• Weston A, Godbold JH. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: A meta-analysis. Environ Health Perspect 1997; 105: 919–926
   PubMed Web of Science ®Google Scholar
• Bonafe M, Olivieri F, Mari D, Baggio G, Mattace R, Berardelli M, Sansoni P, De Benedictis G, De Luca M, Marchegiani F, Cavallone L, Cardelli M, Giovagnetti S, Ferrucci L, Amadio L, Lisa R, Tucci MG, Troiano L, Pini G, Gueresi P, Morellini M, Sorbi S, Passeri G, Barbi C, Valensin S, Monti D, Deiana L, Pes GM, Carru C, Franceschi C. P53 codon 72 polymorphism and longevity: Additional data on centenarians from continental Italy and Sardinia. Am J Hum Genet 1999; 65: 1782–1785
   PubMed Web of Science ®Google Scholar
• Bonafe M, Olivieri F, Mari D, Baggio G, Mattace R, Sansoni P, De Benedictis G, De Luca M, Bertolini S, Barbi C, Monti D, Franceschi C. p53 variants predisposing to cancer are present in healthy centenarians. Am J Hum Genet 1999; 64: 292–295
   PubMed Web of Science ®Google Scholar
• Bonafe M, Barbi C, Storci G, Salvioli S, Capri M, Olivieri F, Valensin S, Monti D, Gonos ES, De Benedictis G, Franceschi C. What studies on human longevity tell us about the risk for cancer in the oldest old: Data and hypotheses on the genetics and immunology of centenarians. Exp Gerontol 2002; 37: 1263–1271
   PubMed Web of Science ®Google Scholar
• van Heemst D, Mooijaart SP, Beekman M, Schreuder J, de Craen AJ, Brandt BW, Slagboom PE, Westendorp RG. Long life study group. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 2005; 40: 11–15
   PubMed Web of Science ®Google Scholar
• Wallace DC. Mitochondrial DNA in aging and disease. Sci Am 1997; 277: 40–47
   PubMed Web of Science ®Google Scholar
• Barthelemy C, Ogier de Baulny H, Diaz J, Cheval MA, Frachon P, Romero N, Goutieres F, Fardeau M, Lombes A. Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation. Ann Neurol 2001; 49: 607–617
   PubMed Web of Science ®Google Scholar
• Miller FJ, Rosenfeldt FL, Zhang C, Linnane AW, Nagley P. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: Lack of change of copy number with age. Nucleic Acids Res 2003; 31: e61
   PubMed Web of Science ®Google Scholar
• Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994; 91: 10771–11078
   PubMed Web of Science ®Google Scholar
• Michikawa Y, Laderman K, Richter K, Attardi G. Role of nuclear background and in vivo environment in variable segregation behavior of the aging-dependent T414G mutation at critical control site for human fibroblast mtDNA replication. Somat Cell Mol Genet 1999; 25: 333–342
   PubMedGoogle Scholar
• Soong NW, Hinton DR, Cortopassi G, Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 1992; 2: 318–323
   PubMed Web of Science ®Google Scholar
• Liu VW, Zhang C, Nagley P. Mutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing. Nucleic Acids Res 1998; 26: 1268–1275
   PubMed Web of Science ®Google Scholar
• Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N, Comi G, Morandi L, Santoro L, Toscano A, Fabrizi GM, Somer H, Croxen R, Beeson D, Poulton J, Suomalainen A, Jacobs HT, Zeviani M, Larsson C. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001; 28: 223–231
   PubMed Web of Science ®Google Scholar
• Chen XJ, Butow RA. The organization and inheritance of the mitochondrial genome. Nat Rev Genet 2005; 6: 815–825
   PubMed Web of Science ®Google Scholar
• Shadel GS. Mitochondrial DNA, aconitase ‘wraps’ it up. Trends Biochem Sci 2005; 30: 294–296
   PubMed Web of Science ®Google Scholar
• Muller-Hocker J. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart—an age-related phenomenon. A histochemical ultracytochemical study. Am J Pathol 1989; 134: 1167–1173
   PubMed Web of Science ®Google Scholar
• Muller-Hocker J, Schneiderbanger K, Stefani FH, Kadenbach B. Progressive loss of cytochrome c oxidase in the human extraocular muscles in ageing—a cytochemical-immunohistochemical study. Mutat Res 1992; 275: 115–124
   PubMedGoogle Scholar
• Kowald A. The mitochondrial theory of aging. Biol Signals Recept 2001; 10(3–4)162–175
   PubMedGoogle Scholar
• Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet 2002; 11: 133–145
   PubMed Web of Science ®Google Scholar
• Chinnery PF, Taylor GA, Howell N, Brown DT, Parsons TJ, Turnbull DM. Point mutations of the mtDNA control region in normal and neurodegenerative human brains. Am J Hum Genet 2001; 68: 529–532
   PubMed Web of Science ®Google Scholar
• Coskun PE, Ruiz-Pesini E, Wallace DC. Control region mtDNA variants: Longevity, climatic adaptation, and a forensic conundrum. Proc Natl Acad Sci USA 2003; 100: 2174–2176
   PubMed Web of Science ®Google Scholar
• Wang Y, Michikawa Y, Mallidis C, Bai Y, Woodhouse L, Yarasheski KE, Miller CA, Askanas V, Engel WK, Bhasin S, Attardi G. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci USA 2001; 98: 4022–4027
   PubMed Web of Science ®Google Scholar
• Zhang J, Asin-Cayuela J, Fish J, Michikawa Y, Bonafe M, Olivieri F, Passarino G, De Benedictis G, Franceschi C, Attardi G. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc Natl Acad Sci USA 2003; 100: 1116–1121
   PubMed Web of Science ®Google Scholar
• Santoro A, Salvioli S, Raule N, Capri M, Sevini F, Monti D, Bellizzi D, Passarino G, Rose G, De Benedictis G, Franceschi C. MtDNA involvement in human longevity. BBA—Bioenergetics 2006, in press
   Google Scholar
• Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly-Y M, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417–423
   PubMed Web of Science ®Google Scholar
• Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, Prolla TA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005; 309: 481–484
   PubMed Web of Science ®Google Scholar
• Trifunovic A, Hansson A, Wredenberg A, Rovio AT, Dufour E, Khvorostov I, Spelbrink JN, Wibom R, Jacobs HT, Larsson NG. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci USA 2005; 102: 17993–17998
   PubMed Web of Science ®Google Scholar
• Sato A, Nakada K, Hayashi J. Mitochondrial dynamics and aging: Mitochondrial interaction preventing individuals from expression of respiratory deficiency caused by mutant mtDNA. BBA 2006, in press
   Web of Science ®Google Scholar
• Torroni A, Wallace DC. Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance. J Bioenerg Biomembr 1994; 26: 261–271
   PubMed Web of Science ®Google Scholar
• Wallace DC. William Allan Award Address. Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 1995; 57: 201–223
   PubMed Web of Science ®Google Scholar
• Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 1994; 91: 8739–8746
   PubMed Web of Science ®Google Scholar
• Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC. Effects of purifyng and adaptive selection on regional variation in human mtDNA. Science 2004; 303: 223–225
   PubMed Web of Science ®Google Scholar
• van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Jr., Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 2003; 72: 804–811
   PubMed Web of Science ®Google Scholar
• van Der Walt JM, Dementieva G, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Doraiswamy PM, Gilbert JR, Haines JL, Vance JM, Pericak-Vance MA. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 2004; 365: 28–32
   PubMed Web of Science ®Google Scholar
• Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, Bonuccelli U, Petrozzi L, Abbruzzese G, Marchese R, Cortelli P, Grimaldi D, Martinelli P, Ferrarese C, Garavaglia B, Sangiorgi S, Carelli V, Torroni A, Albanese A, Zeviani M. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet 2005; 13: 748–752
   PubMed Web of Science ®Google Scholar
• De Benedictis G, Rose G, Carrieri G, De Luca M, Falcone E, Passarino G, Bonafe M, Monti D, Baggio G, Bertolini S, Mari D, Mattace R, Franceschi C. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 1999; 13: 1532–1536
   PubMed Web of Science ®Google Scholar
• Ross OA, McCormack R, Curran MD, Duguid RA, Barnett YA, Rea IM, Middleton D. Mitochondrial DNA polymorphism: Its role in longevity of the Irish population. Exp Gerontol 2001; 36: 1161–1178
   PubMed Web of Science ®Google Scholar
• Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylha M, Majamaa K. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 2003; 112: 29–33
   PubMed Web of Science ®Google Scholar
• Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype associated with longevity. Lancet 1998; 351: 185–186
   PubMed Web of Science ®Google Scholar
• Tanaka M, Gong J, Zhang J, Yamada Y, Borgeld HJ, Yagi K. Mitochondrial genotype associated with longevity and its inhibitory effect on mutagenesis. Mech Ageing Dev 2000; 116: 65–76
   PubMed Web of Science ®Google Scholar
• Tanaka M, Fuku N, Takeyasu T, Guo LJ, Hirose R, Kurata M, Borgeld HJ, Yamada Y, Maruyama W, Arai Y, Hirose N, Oshida Y, Sato Y, Hattori N, Mizuno Y, Iwata S, Yagi K. Golden mean to longevity: Rareness of mitochondrial cytochrome b variants in centenarians but not in patients with Parkinson's disease. J Neurosci Res 2002; 70: 347–355
   PubMed Web of Science ®Google Scholar
• Bellizzi D, Cavalcante P, Taverna D, Rose G, Passarino G, Salvioli S, Franceschi C, De Benedictis G. Gene Expression of cytokines and cytokine-receptors is modulated by common variability of the mitochondrial DNA in cybrid cell lines. Genes Cells 2006, in press
   PubMed Web of Science ®Google Scholar
• Chondrogianni N, Petropoulos I, Franceschi C, Friguet B, Gonos ES. Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 2000; 35: 721–728
   PubMed Web of Science ®Google Scholar
• Mishto M, Bonafe M, Salvioli S, Olivieri F, Franceschi C. Age dependent impact of LMP polymorphisms on TNFalpha-induced apoptosis in human peripheral blood mononuclear cells. Exp Gerontol 2002; 37: 301–308
   PubMed Web of Science ®Google Scholar
• Mishto M, Santoro A, Bellavista E, Bonafe M, Monti D, Franceschi C. Immunoproteasomes and immunosenescence. Ageing Res Rev 2003; 2: 419–432
   PubMed Web of Science ®Google Scholar
• Mishto M, Santoro A, Bellavista E, Sessions R, Textoris-Taube K, Dal Piaz F, Carrard G, Forti K, Salvioli S, Friguet B, Kloetzel PM, Rivett AJ, Franceschi C. A structural model of 20S immunoproteasomes: Effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms. Biol Chem 2006; 387: 417–429
   PubMed Web of Science ®Google Scholar
• Mishto M, Bellavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B, Spazzafumo L, Chiappelli M, Licastro F, Sorbi S, Pession A, Ohm T, Grune T, Franceschi C. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol Aging 2006; 27: 54–66
   PubMed Web of Science ®Google Scholar
• Stratford FL, Chondrogianni N, Trougakos IP, Gonos ES, Rivett AJ. Proteasome response to interferon-gamma is altered in senescent human fibroblasts. FEBS Lett 2006; 580: 3989–3994
   PubMed Web of Science ®Google Scholar
• Atzmon G, Schechter C, Greiner W, Davidson D, Rennert G, Barzilai N. Clinical phenotype of families with longevity. J Am Geriatr Soc 2004; 52: 274–277
   PubMed Web of Science ®Google Scholar
• Terry DF, Wilcox MA, McCormick MA, Pennington JY, Schoenhofen EA, Andersen SL, Perls TT. Lower all-cause, cardiovascular, and cancer mortality in centenarians' offspring. J Am Geriatr Soc 2004; 52: 2074–2076
   PubMed Web of Science ®Google Scholar
• Terry DF, Wilcox M, McCormick MA, Lawler E, Perls TT. Cardiovascular advantages among the offspring of centenarians. J Gerontol A Biol Sci Med Sci 2003; 58: M425–M431
   PubMed Web of Science ®Google Scholar
• Karasik D, Hannan MT, Cupples LA, Felson DT, Kiel DP. Genetic contribution to biological aging: The Framingham study. J Gerontol A Biol Sci Med Sci 2004; 59: 218–226
   PubMed Web of Science ®Google Scholar
• Ikeda A, Iso H, Toyoshima H, Kondo T, Mizoue T, Koizumi A, Inaba Y, Tamakoshi A. JACC study group. Parental longevity and mortality amongst Japanese men and women: The JACC Study. J Intern Med 2006; 259: 285–295
   PubMed Web of Science ®Google Scholar
• Perls TT, Wilmoth J, Levenson R, Drinkwater M, Cohen M, Bogan H, Joyce E, Brewster S, Kunkel L, Puca A. Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci USA 2002; 99: 8442–8847
   PubMed Web of Science ®Google Scholar
• Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, Slagboom PE, Westendorp RG. Evidence of genetic enrichment for exceptional survival using a family approach: The Leiden longevity study. Eur J Hum Genet 2006; 14: 79–84
   PubMed Web of Science ®Google Scholar
• Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P, Fagiolo U, Castellani G, Bersani F, Londei M, Franceschi C. CD45 isoforms expression on CD4+ and CD8+T cells throughout life, from newborns to centenarians: Implications for T cell memory. Mech Ageing Dev 1996; 86: 173–195
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafe M, Valensin S. Human immunosenescence: The prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18: 1717–1720
   PubMed Web of Science ®Google Scholar
• Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000; 95: 2860–2868
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244–254
   PubMed Web of Science ®Google Scholar
• Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin AI, Monti D, De Benedictis G. The network and the remodeling theories of aging: Historical background and new perspectives. Exp Gerontol 2000; 35: 879–896
   PubMed Web of Science ®Google Scholar
• Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di Pede P, Lucchini G, Zanlari L, Passeri G, Zanni F, Chezzi C, Franceschi C, Sansoni P. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp Gerontol 2004; 39: 1233–1243
   PubMed Web of Science ®Google Scholar
• Poulain M, Pes GM, Grasland C, Carru C, Ferrucci L, Baggio G, Franceschi C, Deiana L. Identification of a geographic area characterized by extreme longevity in the Sardinia island: The AKEA study. Exp Gerontol 2004; 39: 1423–1429
   PubMed Web of Science ®Google Scholar
• Ginaldi L, De Martinis M, Monti D, Franceschi C. Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol 2005; 26: 79–84
   PubMed Web of Science ®Google Scholar
• De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005; 579: 2035–2039
   PubMed Web of Science ®Google Scholar
• De Benedictis G, Franceschi C. The unusual genetics of human longevity. Sci Aging Knowledge Environ 2006; 2006: pe20
   PubMedGoogle Scholar